EDGAR Filing Documents for 0001171843-17-004383

Form 8-K - Current report:

SEC Accession No. 0001171843-17-004383

Filing Date

2017-07-27

Accepted

2017-07-27 10:46:03

Documents

Period of Report

2017-07-27

Items

Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	f8k_072717.htm	8-K	8438
2	PRESS RELEASE	exh_991.htm	EX-99.1	6480
	Complete submission text file	0001171843-17-004383.txt		16199

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8

Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200

Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 17984960
SIC: 2834 Pharmaceutical Preparations